OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
Brian Godman, Magdałene Władysiuk, Stuart McTaggart, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 8
Brian Godman, Magdałene Władysiuk, Stuart McTaggart, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 8
Showing 8 citing articles:
The global burden of disease attributable to metabolic risks in 204 countries and territories from 1990 to 2019
Wanqin Hu, Chunxia Zhai, Hongyu Sun, et al.
Diabetes Research and Clinical Practice (2023) Vol. 196, pp. 110260-110260
Closed Access | Times Cited: 11
Wanqin Hu, Chunxia Zhai, Hongyu Sun, et al.
Diabetes Research and Clinical Practice (2023) Vol. 196, pp. 110260-110260
Closed Access | Times Cited: 11
Could high continuity of care (COC) have a negative impact on subjective health of hypertensive patients? A Japanese perspective
Narimasa Kumagai, Shuzo Nishimura, Mihajlo Jakovljević
Cost Effectiveness and Resource Allocation (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Narimasa Kumagai, Shuzo Nishimura, Mihajlo Jakovljević
Cost Effectiveness and Resource Allocation (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
Godman Brian, Tubic Biljana, Allocati Eleonora, et al.
Journal of Applied Pharmaceutical Science (2022)
Open Access | Times Cited: 7
Godman Brian, Tubic Biljana, Allocati Eleonora, et al.
Journal of Applied Pharmaceutical Science (2022)
Open Access | Times Cited: 7
New Insulins, Biosimilars, and Insulin Therapy
Thomas Danne, Lutz Heinemann, Thomas R. Pieber
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. S1, pp. S-69
Closed Access | Times Cited: 2
Thomas Danne, Lutz Heinemann, Thomas R. Pieber
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. S1, pp. S-69
Closed Access | Times Cited: 2
Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care
Ileana Mardare, Stephen Campbell, Johanna C. Meyer, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 3
Ileana Mardare, Stephen Campbell, Johanna C. Meyer, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 3
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
Soheila Rezaei, Ali Taheri, Saeed Taheri, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 6, pp. 767-777
Closed Access | Times Cited: 3
Soheila Rezaei, Ali Taheri, Saeed Taheri, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 6, pp. 767-777
Closed Access | Times Cited: 3
Regulatory aspects of biological medicines in Bosnia and Herzegovina
Biljana Tubić, Saša Jungić
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 1
Biljana Tubić, Saša Jungić
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 1
Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
Brian Godman, Magdałene Władysiuk, Stuart McTaggart, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access
Brian Godman, Magdałene Władysiuk, Stuart McTaggart, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access
